Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
about
Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomasOverexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.In silico analysis identifies genes common between five primary gastrointestinal cancer sites with potential clinical applications.High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningA monoclonal antibody against a potential cancer biomarker, human ubiquitin-conjugating enzyme E2Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.Molecular markers of aggressiveness of thyroid cancer.Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.Somatic amplifications and deletions in genome of papillary thyroid carcinomas.UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1.Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.
P2860
Q30491720-97482175-5C7E-494F-B825-5A1A26F372FFQ33420103-8364B82D-DED8-433A-A0C0-17B1D5BDFAB1Q33691759-0C15C129-7B0A-4158-9970-FB43CA34AC29Q33813427-3B10640D-A5D3-4F0F-A18D-546662D4955EQ34669229-BAE77055-AD7C-4078-942C-E5CD95562D5FQ35797331-F264FB96-E249-4D04-8006-7EF76F6222E0Q36066046-3AA5742F-5257-4495-AA6B-7E256CE946B7Q36618604-8C648953-60A9-4261-B941-2623B38F3B33Q37526750-A43EDA49-F9C4-441E-9CE8-84DD021B8372Q37544168-0820CCF5-DC5B-443A-A4E5-588D7FC8948EQ37708370-15AB8939-424B-4C72-A188-FA363CC404DCQ38441002-D81EEE7E-EA65-492A-895B-F81ACF7BFA81Q41088523-99BD1675-08FC-4B76-9AC2-9637B9B3E91CQ52338003-A0241730-9507-4E89-9F83-45B8983A5F90Q54334498-9EFF5D9F-F3A2-45CB-B520-561D34E4BED7
P2860
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@en
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@nl
type
label
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@en
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@nl
prefLabel
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@en
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@nl
P2093
P356
P1476
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
@en
P2093
Amy Y M Au
Anders Höög
Bruce G Robinson
Catharina Larsson
Göran Wallin
Jia-Jing Lee
Johan Staaf
Leigh Delbridge
Michela Barbaro
P304
P356
10.1677/ERC-08-0018
P577
2008-09-01T00:00:00Z